Paper37481069
Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies.
Xia D and 3 others. Am J Pathol, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies. Papers, record 37481069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37481069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Heart Failure | Major topic |
| Humans | |
| Mitochondria | |
| Antioxidants |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518777 | The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42518777 | PubMed |
| 42450802 | Selenium Attenuates LPS-Induced Injury in Ovine Granulosa Cells by Protecting Mitochondrial Ultrastructure and Cellular Homeostasis. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42450802 | PubMed |
| 41352451 | Exercise attenuates the hallmarks of aging: Novel perspectives. | J Sport Health Sci | 2025 | https://conductscience.org/library/papers/41352451 | PubMed |
| 41291747 | Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41291747 | PubMed |
| 41251648 | Novel Allogeneic Mitochondria and Associated Organelle Complex Treatment Prevents Myocardial Ischemia-Reperfusion Injury Through Anti-Apoptotic Effects. | JACC Asia | 2026 | https://conductscience.org/library/papers/41251648 | PubMed |
| 41244322 | Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. | Cell Insight | 2025 | https://conductscience.org/library/papers/41244322 | PubMed |
| 41226535 | Mitochondrial Dysfunction in the Cardiovascular Disease Continuum: Problems of Studying the Progression During the Follow-Up of the Pathologies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226535 | PubMed |
| 41148836 | Advances in Mitochondrial Dysfunction and Its Role in Cardiovascular Diseases. | Cells | 2025 | https://conductscience.org/library/papers/41148836 | PubMed |
| 40593725 | Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation. | Nat Commun | 2025 | https://conductscience.org/library/papers/40593725 | PubMed |
| 40563375 | Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia-Focus on the NO System. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563375 | PubMed |
| 40182153 | Cardioprotective strategies in myocardial ischemia-reperfusion injury: Implications for improving clinical translation. | J Mol Cell Cardiol Plus | 2025 | https://conductscience.org/library/papers/40182153 | PubMed |
| 40115104 | Advances in Chinese herbal medicine in modulating mitochondria to treat myocardial ischemia-reperfusion injury: a narrative review. | Cardiovasc Diagn Ther | 2025 | https://conductscience.org/library/papers/40115104 | PubMed |
| 39588041 | Association between oxidative balance score and cardiovascular diseases: mediating analysis of methylmalonic acid based on the NHANES database. | Front Nutr | 2024 | https://conductscience.org/library/papers/39588041 | PubMed |
| 39525282 | Impact of photobleaching on quantitative, spatio-temporal, super-resolution imaging of mitochondria in live C. elegans larvae. | Npj Imaging | 2024 | https://conductscience.org/library/papers/39525282 | PubMed |
| 39400015 | Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/39400015 | PubMed |
| 39226171 | Aldehyde dehydrogenase 2 preserves kidney function by countering acrolein-induced metabolic and mitochondrial dysfunction. | JCI Insight | 2024 | https://conductscience.org/library/papers/39226171 | PubMed |
| 38980593 | Insight into the cardioprotective effects of melatonin: shining a spotlight on intercellular Sirt signaling communication. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/38980593 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37481069
GET https://conductscience.org/api/papers/v1/37481069/authors